Patients Depression
Spravato: antidepressant for treatment-resistant depression. Have you tried?
- 10 views
- 0 support
- 1 comment
All comments
Joined in 2020
201 comments posted |
11 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Committed
-
Explorer
Polina.K
Community managerGood advisor
Polina.K
Community manager
Last activity on 08/11/2023 at 11:55 AM
Joined in 2023
138 comments posted | 26 in the Depression Forum
4 of their responses were helpful to members
Rewards
Good Advisor
Contributor
Messenger
Explorer
Evaluator
Friend
Hello everyone! How are you today?
Spravato (esketamine) nasal spray, in combination with an oral antidepressant, was approved by the U.S. Food and Drug Administration in 2019 for the treatment of depression for people who have tried previous antidepressant medications but have not benefited from them (treatment-resistant depression).
@Forest92 @SurajRoy @Boymom09 @bonkistobias♡ @williamjacob @Lollo4 @Charlie77 @Arn_US @Dr.WhoPeggygmail.com @Mrspeedy @kisslamarre @charding8290 @Tescott1981 @Doug_RVA @chais18a
Have you heard of it? Have you tried it or would you want to try it? What do you think?
Take care,
Polina from the Carenity team